0001493152-24-015879.txt : 20240425 0001493152-24-015879.hdr.sgml : 20240425 20240425113735 ACCESSION NUMBER: 0001493152-24-015879 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZIRR JAMES C CENTRAL INDEX KEY: 0001260641 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 24874115 MAIL ADDRESS: STREET 1: 4908 SOUTH ASHTON COURT CITY: SPOKANE STATE: WA ZIP: 99223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 5 1 ownership.xml X0508 5 2023-12-31 0 0 0 0001133416 GALECTIN THERAPEUTICS INC GALT 0001260641 CZIRR JAMES C 4908 S. ASHTON CT. SPOKANE, WA 99223 0 0 1 0 0 Common Stock 2023-03-31 5 J 0 1000 6.00 A 761616 D Common Stock 2023-09-30 5 J 0 1000 6.00 A 762616 D Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividends were payable on 3/31/2020 and 9/30/2020. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend. Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9. /s/ James C. Czirr 2024-04-25